→ Less than two months after German biotech BioNTech raised a herculean $325 million in an upsized round of financing — the Bill and Melinda Gates Foundation have signed a pact with the company, making an initial equity investment of $55 million to develop vaccine and immunotherapy candidates to prevent HIV and tuberculosis. Total funding under … Continue reading BioNTech partners with Bill and Melinda Gates Foundation, scoring $55M equity investment; BeiGene brushes off short attack